[1]
“Formulation and Evaluation of Titanium Dioxide Nanoparticles encapsulating Enzalutamide for Sustained drug delivery”, JOC, vol. 24, no. 8s, pp. 458–467, Oct. 2025, doi: 10.64149/J.Carcinog.24.8s.458-467.